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Abstract
Objectives
To compare 10-minute delayed hepatocyte phase imaging using a 30° flip angle (10min-
FA30) and 20-minute hepatocyte phase imaging using a 10° FA (20min-FA10) in gadoxetic
acid-enhanced MRI of patients with possible liver metastases, regarding lesion-to-liver con-
trast-to-noise ratio (CNR) and focal hepatic lesion (FHL) detection to evaluate whether
10min-FA30 would be superior to 20min-FA10.
Materials and Methods
Eighty-three patients with 248 liver metastases and 78 benign FHLs who underwent
gadoxetic acid-enhanced MRI with 10min-FA30 and 20min-FA10 were enrolled. Lesion-to-
liver CNRs were compared between the two image groups. Two radiologists independently
assessed the presence of FHLs using a four-point scale and detection sensitivity was
calculated.
Results
The mean CNR for liver metastases on the 10min-FA30 (248.5 ± 101.6) were significantly
higher than that of the 20min-FA10 (187.4 ± 77.4) (p < 0.001). The mean CNR difference
between the two image groups was 61.2 ± 56.8. There was no significant difference in
detection sensitivity of FHLs for two readers between 10min-FA30 (mean 97.7%) and
20min-FA10 (mean 97.9%), irrespective of the lesion size or malignancy.
Conclusion
10min-FA30 yielded higher CNR with similar sensitivity compared to 20min-FA10. This find-
ing indicates that 10min-FA30 can potentially replace 20min-FA10 with higher diagnostic
performance and save 10 minutes of time.
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Introduction
Gadoxetic acid (Gd-EOB-DTPA) is a liver-specific magnetic resonance imaging (MRI) con-
trast agent that is widely used for both dynamic and hepatocyte-specific imaging [1]. This com-
pound is taken up continuously by hepatocytes 1 minute after contrast administration, and
increases the signal intensity of the liver parenchyma on the delayed phase imaging. Hepato-
cyte phase imaging (HPI) obtained at 20 minutes after injection of gadoxetic acid [2–5] has
been proven to improve detection of focal hepatic lesions (FHLs), including liver metastases
[6–12].
Several studies have shown that the time delay for HPI after injection of gadoxetic acid can
be decreased less than 20 minutes. Many studies have shown that 10-minute delayed HPI pro-
vided satisfactory information for the detection and characterization of FHL. However, the
lesion-to-liver contrast-to-noise ratio (CNR) or signal ratio obtained on 10-minute delayed
hepatocyte phase images was significantly lower than that of the conventional imaging with
20-minute delay [13–16].
HPI is usually obtained with a T1-weighted (T1W) fat-suppressed (FS) three-dimensional
(3D) gradient echo (GRE) sequence with a low flip angle (FA) ranging from 10° to 15°. Gener-
ally, a low FA has been used in nonspecific extracellular gadolinium chelate-enhanced dynamic
T1W 3D GRE sequence, which increases liver-to-spleen CNR and allows shortening of TR and
short acquisition time [17]. However, with the use of high FA (30–35°) in HPI after injection of
gadoxetic acid has been shown to improve both lesion-to-liver CNR and FHL detection in
many studies [18–21], since the high FA intensifies T1-weighting [19].
On a previous study [22], using 5 minute delayed HPI with 30° flip angle showed statisti-
cally increased CNR in hepatocellular carcinoma (HCC), but not in the metastatic lesions,
compared to 20 minute delayed HPI with 10° flip angle. Therefore, 5 minute delayed imaging
seemed not to be sufficient enough to replace 20 minute delayed imaging for detection of meta-
static lesions of the liver.
Therefore, the purpose of this study was to compare the lesion-to-liver CNR and lesion
detection sensitivity of a HPI protocol with a 10-minute delay and a 30° FA (10min-FA30)
with those of a standard HPI protocol with a 20-minute delay and a 10° FA (20min-FA10) in
patients with liver metastases. Our motivation for this comparison was to determine whether
the 10min-FA30 protocol would be superior to the 20min-FA10 protocol with respect to
lesion-to-liver CNR, detection sensitivity and reduce the delay time.
Materials and Methods
The Gangnam Severance Hospital institutional review board (IRB) approved this retrospective
study and written informed consent was waived. Patient records were anonymized and de-
identified prior to analysis.
Study Population and Standard reference
FromMarch 2013 to July 2014, 93 consecutive patients with known or suspected liver metasta-
sis from colorectal cancer underwent gadoxetic acid-enhanced MRI examination. Ten patients
were excluded from our study because the final diagnosis was not available due to the lack of a
reference standard. Of the remaining 83 patients, 78 had confirmed liver metastases and the
remaining five had either benign lesions (n = 2) or no FHL (n = 3). To prevent the reviewing
radiologists from assuming that all patients had liver metastasis, the five patients with benign
or no FHL were also included. Therefore, a total of 83 patients (45 men, 38 women; mean age,
58 years; range, 29–81 years) with 248 liver metastases and 78 benign FHLs were analyzed. The
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patients had no underlying diffuse or cirrhotic liver disease. The primary malignancies of the
patients presenting with liver metastases were colon cancer (n = 46) and rectal cancer (n = 37).
Among the 78 benign lesions (70 cysts, 7 hemangiomas, and 1 focal eosinophilic necrosis),
one hemangioma was diagnosed pathologically by surgery. The other benign lesions were diag-
nosed based on laboratory findings, typical characteristic imaging criteria [18–23], and their
non-progressive appearance in size on follow-up imaging studies and in examinations that
took place before the study period.
Among the 248 metastatic tumors, 78 lesions were diagnosed pathologically (73 by resection
and 5 by biopsy). The remaining 170 metastases in patients with the aforementioned primary
malignancies were diagnosed based on the imaging findings that were similar to those of
biopsy-proven metastatic tumors and their progressive appearance on follow-up imaging
studies.
Image Acquisition
All MRI examinations were performed with a 1.5 T scanner (Magnetom Avanto, a TIM system;
Siemens Medical Solutions, Erlangen, Germany) using a 16-channel torso phased-array coil
centered over the liver. The sequence protocol consisted of: breath-hold (BH) two-dimensional
(2D) axial and coronal half-Fourier acquisition single-shot turbo spin-echo (HASTE); BH 2D
axial GRE T1-weighted images with 2-point Dixon reconstructions; pre-contrast and dynamic
3D axial FS T1W volumetric interpolated breath-hold examination (VIBE) during the arterial,
portal venous, 3- and 5-minute delayed dynamic phase; BH 2D axial T2W turbo spin-echo
images, 10-minute delayed BH 3D axial FS T1W VIBE imaging; navigator-echo triggered FS
2D axial diffusion-weighted images using prospective acquisition correction; 20-minute
delayed BH 3D axial FS T1W VIBE images.
Post-contrast MRI examination were performed with an intravenous infusion of 0.025
mmol/kg of gadoxetic acid (Primovist, Bayer Schering Pharma, Berlin, Germany) at a rate of 1
mL/s, followed by a 20 mL saline flush at the same injection rate. Infusions were administered
with a mechanical power injector (MedRad Spectris Solaris EP, Medrad, Indianola, PA, USA)
through a 20-gauge catheter inserted into an antecubital vein.
During 10-minute delayed phase imaging, 3D axial FS T1W VIBE images were acquired
using a 30° FA. The other 3D axial FS T1W VIBE images (dynamic and 20-minute delayed
imaging) were acquired using 10° FA. The 3D VIBE sequence parameters were as follows: TR
5.1 msec, TE 2.4 msec, receiver bandwidth 300 Hz/pixel, matrix 256 x 179, parallel acceleration
factor 2 using the GRAPPA algorithm, slice thickness 2.8 mm, k-space trajectory rectangular
(FA 10°) and central (FA 30°) ordering, and acquisition time of 14–15 seconds at both 10° FA
and 30° FA imaging.
Quantitative Image Analysis
Each metastatic hepatic tumor was classified as either large (short axis10 mm) or small
(short axis<10 mm). Tumor diameter was measured on the 20-minute delayed HPI. Quantita-
tive analysis was performed by a coordinating radiologist who also attended in the confirma-
tion of hepatic lesions. The signal intensities of each metastatic tumor and the surrounding
normal liver parenchyma were measured on two imaging sets (10min-FA30 and 20min-FA10).
Image noise was defined as the standard deviation of background signal intensity anterior to
the liver and outside of the body. The measurements were performed three times, and the
mean value was used for lesion-to-liver CNR calculation as follows: CNR = (SILiver—SITumor)/
SDNoise, where SILiver = mean signal intensity of the liver parenchyma, SITumor = mean signal
intensity of metastatic tumor, and SDNoise = mean standard deviation of the background.
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Qualitative Image Analysis
Two radiologists who had 17 years and 8 years of experience in the MR imaging of the liver
independently and randomly evaluated the two imaging sets (10min-FA30 and 20min-FA10).
Images were analyzed 4–6 weeks apart to avoid recall bias. Moreover, individual sequences
were randomly assigned to either the first or second reading. All images were assessed on a pic-
ture archive and communication systems workstation (Centricity RA1000, GE Healthcare,
Milwaukee, USA). The images were adjusted to an optimal window setting for each case.
The radiologists evaluated the presence of hepatic lesions on each image based on the fol-
lowing four-point confidence scale: 1 = definitely absent (no identifiable lesion), 2 = probably
absent (questionable), 3 = probably present, 4 = definitely present. All evaluated lesions were
marked with arrows and numbers, and the resultant images were saved digitally on the work-
station. A coordinating radiologist with 4 years of experience in liver MRI, who was not
involved in the qualitative reading session, matched MRI findings to those of the reference
standard.
Statistical Analysis
All statistical analyses were performed using dedicated statistical software (SPSS 12.0; SPSS,
Chicago, IL, USA). Sensitivities were calculated for the detection of all FHLs. Confidence scores
of 1 and 2 were regarded as negative for the presence of a FHL, whereas confidence scores of 3
and 4 were considered as positive for the presence of a FHL. The sensitivities of the FHL detec-
tion on both 10min-FA30 and 20min-FA10 were compared using a Wilcoxon signed-rank test.
Lesion-to-liver CNRs of large metastatic tumors (short axis 10 mm) were compared between
groups by paired Student’s t-test. The kappa statistics was used to assess inter-reader agreement
with respect to scoring and was interpreted according to the guidelines of Landis and Koch
[23]. Significant differences were defined as those with p values less than 0.05.
Results
Of the 248 metastatic tumors, 202 lesions with a short axis longer than 10 mm were quantita-
tively measured. The other 46 lesions, smaller than 10 mm, were not quantitatively analyzed.
The mean CNR for liver metastases imaged with the 10min-FA30 (248.5 ± 101.6) was signifi-
cantly higher than that of the metastases imaged with the 20min-FA10 (187.4 ± 77.4)
(p< 0.001). Additionally, the mean CNR difference between the two image groups was
61.2 ± 56.8 (Fig 1). Moreover, 186 tumors out of 202 liver metastases with short axis 10 mm
had a higher CNR with the 10min-FA30 protocol (Fig 2), whereas the other 16 tumors had a
higher CNR with the 20min-FA10 protocol.
The FHL detection sensitivities of the two imaging protocols are provided in Table 1. No
significant differences were observed between two imaging protocols with respect to sensitivity
for either reader, irrespective of lesion malignancy; benignity; or FHL size. Two small false pos-
itive lesions were detected by reader A and one by reader B; both depicted on 20min-FA10 pro-
tocol. The interobserver agreement between the two readers was substantial (0.725).
Discussion
To achieve the maximum hepatic parenchymal enhancement in gadoxetic acid enhanced MRI,
it is important to wait for the functioning hepatocytes to take up a sufficient amount of gadoxe-
tic acid [14, 24]. Based on preliminary evaluations of gadoxetic acid, a delay time of 20 minutes
after contrast injection has been proposed and used for HPI [2–4]. Since the introduction of
the 20-minute delay, most MRI studies using gadoxetic acid have used this protocol [5, 9–11,
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25–30]. However, considering recent development in MR imaging and clinical application, a
delay time of 20 minutes may no longer be necessary. Decreasing this delay time would
Fig 1. Lesion-to-liver contrast-to-noise ratio (CNR). Box-and-whisker plots showing the median (middle
line of each box), quartiles (top and bottom lines of each box), and upper and lower adjacent (upper and lower
whiskers for each box) values of the lesion-to-liver contrast-to-noise ratio (CNR). Liver metastases were
imaged according to two different protocols: 10 minute delayed hepatocyte phase imaging with a 30° flip
angle (10min-FA30) and 20 minute delayed hepatocyte phase imaging with a 10° flip angle (20min-FA10).
The mean CNR for FHLs imaged with the 10min-FA30 protocol was significantly higher than that of FHLs
imaged with the 20min-FA10 protocol.
doi:10.1371/journal.pone.0139863.g001
Fig 2. 43-year-old male with pathologically proven liver metastasis from rectal cancer.Gadoxetic acid-enhanced T1-weighted MR hepatocyte phase
images taken with a 10-minute delay and a 30° flip angle (10min-FA30) (a) and a 20-minute delay and a 10° flip angle (20min-FA10) (b). The liver metastasis
in segment 4 showed low signal intensity related to liver parenchyma on both images (dark arrows). The lesion-to-liver CNR of the 10min-FA30 image (190.3)
was superior to that of the 20min-FA10 image (137.3). Two different radiologists each gave the 10min-FA30 and 20min-FA10 images a mean subjective
score for focal hepatic lesion presence of 4.0.
doi:10.1371/journal.pone.0139863.g002
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potentially improve throughput and be more economical [16]. In addition, a decreased delay
time would improve patient discomfort during the MRI procedure.
Many groups have investigated to reduce the delay time for the hepatocyte phase in gadoxe-
tic acid-enhanced MRI [13–16, 31]. Although early reports found that a 20-minute delay was
required to achieve adequate HPI [2, 4, 16], later studies found that the accuracy of FHL and
liver metastasis detection was comparable between hepatocyte phase images obtained with
either a 10-minute delay or a 20-minute delay [13–16]. However, the liver parenchymal
enhancement or lesion-to-liver signal ratios were shown to be higher when a 20-minute delay
was used compared with a 10-minute delay [2, 4, 13, 16]. In addition, one recent report showed
that liver parenchymal enhancement, CNR and SNR of hepatocyte phase images acquired after
a 10-minute delay were either greater than or similar to those acquired after a 20-minute delay
in patients with normal liver function [15].
T1-weighted GRE sequence uses small flip angle and short repetition time value to reduce
the total scan time. Due to the relatively short repetition time, longitudinal magnetization is
incompletely recovered at the relatively short repetition time. This effect is more evident for
FHLs without gadoxetic acid uptake, which has a longer T1 relaxation time, compared with
enhanced liver parenchyma, which has a shorter T1 relaxation time. This difference in residual
longitudinal magnetization is amplified by increasing FA. Thus, increasing the FA also im-
proves T1-weighting and provides a greater contrast between FHLs without gadoxetic acid
uptake and enhanced liver parenchyma. Therefore, increased FA has been proposed to yield a
Table 1. Detection Sensitivity of Focal Hepatic Lesion for the Two Readers on 10-minute Delayed
Hepatocyte Phase Imaging using a 30° Flip Angle (10min-FA30) and 20-minute Delayed Hepatocyte
Phase Imaging using a 10° Flip Angle (20min-FA10).
Delayed time & FA Reader A Reader B
All lesions
10min-FA30 98.5% (321/326; 0) 96.9% (316/326; 0)
20min-FA10 98.8% (322/326; 1) 96.9% (316/326: 2)
P value P = 0.564 P > 0.999
Large lesions
10min-FA30 100% (247/247; 0) 99.2% (245/247; 0)
20min-FA10 100% (247/247; 0) 99.2% (245/247; 0)
P value P > 0.999 P > 0.999
Small lesions
10min-FA30 93.7% (74/79; 0) 89.9% (71/79; 0)
20min-FA10 94.9% (75/79; 1) 89.9% (71/79; 2)
P value P = 0.564 P > 0.999
Malignant lesions
10min-FA30 99.2% (246/248) 97.6% (242/248)
20min-FA10 98.8% (245/248) 96.4% (239/248)
P value P = 0.317 P = 0.180
Benign lesions
10min-FA30 96.2% (75/78) 94.9% (74/78)
20min-FA10 98.7% (77/78) 98.7% (77/78)
P value P = 0.157 P = 0.083
Data in parentheses are true-positive lesions/all focal hepatic lesions and number of false-positive lesions.
Large lesions are focal hepatic lesions 10 mm or greater in short axis. Small lesions are focal hepatic
lesions less than 10 mm in short axis.
doi:10.1371/journal.pone.0139863.t001
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better lesion-to-liver CNR and to improve FHL detection [19, 20]. Based on this hypothesis we
tried to use higher FA to reduce the delayed time for HPI.
From previous reports, the mean lesion-to-liver CNR or contrast ratio on hepatocyte phase
images obtained with a high FA (30–35°) were significantly higher than those obtained with a
low FA (10–12°), with delays of 5, 10, 15, and 20 minutes [18, 20]. The mean lesion-to-liver
contrast ratio of images acquired with a 30° FA after a 10-minute delay (3.96 ± 1.66) was higher
than that of images acquired with a 10° FA and a 20-minute delay (2.27 ± 0.62), although statis-
tical analysis was not performed. This result is in agreement with our results, as we found that
the mean CNR of metastatic tumors on 10min-FA30 images (248.5 ± 101.6) was higher than
that of metastatic tumors on 20min-FA10 images (187.4 ± 77.4).
Previously, a study to shorten the delayed time from 20 minutes to 5 minutes was conducted
with 30° flip angle in gadoxetic acid-enhanced MRI. On the study, 5 minute delayed HPI with
30° FA showed increased lesion-to-liver CNR for HCC, but did not show sufficient results for
metastatic lesions compared to the conventional 20 minute delayed HPI with 10° FA. The dif-
ferent results between the HCC and metastatic lesions are not clearly understood. However, for
the evaluation of the liver metastasis, at least 10 minute delay seems to be required.
Using 3.0T MR imaging, no significant difference in the sensitivity of liver metastasis detec-
tion was observed between procedures using a standard 10–13° FA and a delay of either 10 or
20 minutes [13, 14]. One previous study, which used a higher FA [20], found that the detection
sensitivities for FHLs (including metastases) with a protocol using a 30° FA and a 10-minute
delay (mean 96.5%) were higher than those obtained using a 10° FA and a 20-minute delay
(mean 91.0%); however, no statistical analysis was performed. Our study also found no signifi-
cant difference in the sensitivity of detection of FHLs between the 10min-FA30 and 20min-
FA10 protocols, irrespective of lesion size or malignancy.
While using a higher FA to improve lesion-to-liver CNR, it also increases the energy deposi-
tion in patient’s tissue by radiofrequency field, which is expressed as the specific absorption
rate (SAR). The SAR increases with field strength, radiofrequency power, duty cycle, transmit-
ter-coil type, and body size. Moreover, the SAR is proportional to the square of the FA. There-
fore, increasing the FA from 10° to 30° results in a nine-fold increase in the SAR. Although this
increase is not usually problematic at 1.5T, it can be challenging for 3.0T MR imaging, where
the baseline SAR is already quadrupled compared with that of 1.5 T imaging [19, 20].
There were some limitations in this study. Firstly, our study was retrospective and all of the
FHLs could not all be diagnosed pathologically. Nevertheless, an experienced abdominal radi-
ologist reviewed all clinical and follow-up information for the final diagnosis in each case that
lacked pathologic correlation. Secondly, the CNR of small FHLs with short axis<10 mm was
not analyzed. To minimize the effect of partial volume artifacts, signal intensity was only mea-
sured for large lesions with a short axis 10 mm. Third, in this a HPI protocol with a 30° FA
and a 20-minute delay was not analyzed because previous reports did not find any significant
difference in FHL detection sensitivities for high or low FA imaging protocols with either a 15-
or 20-minute delay [20]. Finally, none of the patients enrolled in this study had chronic hepati-
tis or cirrhosis. Varying degrees of chronic liver disease might influence the detection sensitiv-
ity of FHLs or lesion-to-liver CNR on HPI. Thus, further studies are needed for this matter.
In conclusion, the gadoxetic acid-enhanced MRI protocol for HPI with a high FA (30°) and
a 10-minute delay yielded a higher lesion-to-liver CNR compared with a standard protocol
with a low FA (10°) and a 20-minute delay. In addition, no significant difference was observed
between the two protocols regarding lesion detection sensitivity. These results may suggest that
the 10min-FA30 protocol can replace the 20min-FA10 protocol with better diagnostic perfor-
mance in the detection of liver metastases and also saves 10 minutes in selected patients.
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